266 related articles for article (PubMed ID: 15027326)
1. [Functional role of dopamine D4 receptor in schizophrenia].
Semba J
Nihon Shinkei Seishin Yakurigaku Zasshi; 2004 Feb; 24(1):13-20. PubMed ID: 15027326
[TBL] [Abstract][Full Text] [Related]
2. [Functional role of dopamine D3 receptor in schizophrenia].
Semba J
Nihon Shinkei Seishin Yakurigaku Zasshi; 2004 Feb; 24(1):3-11. PubMed ID: 15027325
[TBL] [Abstract][Full Text] [Related]
3. Dopamine D3 and D4 receptor antagonists in the treatment of schizophrenia.
Jardemark K; Wadenberg ML; Grillner P; Svensson TH
Curr Opin Investig Drugs; 2002 Jan; 3(1):101-5. PubMed ID: 12054059
[TBL] [Abstract][Full Text] [Related]
4. The dopamine D4 receptors and mechanisms of antipsychotic atypicality.
Wong AH; Van Tol HH
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Oct; 27(7):1091-9. PubMed ID: 14642969
[TBL] [Abstract][Full Text] [Related]
5. Tonic modulation of inhibition by dopamine D4 receptors in the rat hippocampus.
Romo-Parra H; Aceves J; Gutiérrez R
Hippocampus; 2005; 15(2):254-9. PubMed ID: 15476261
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and evaluation of chromen-2-ones as potent and selective human dopamine D4 antagonists.
Kesten SR; Heffner TG; Johnson SJ; Pugsley TA; Wright JL; Wise LD
J Med Chem; 1999 Sep; 42(18):3718-25. PubMed ID: 10479303
[TBL] [Abstract][Full Text] [Related]
7. Low density of dopamine D4 receptors in Parkinson's, schizophrenia, and control brain striata.
Seeman P; Guan HC; Van Tol HH; Niznik HB
Synapse; 1993 Aug; 14(4):247-53. PubMed ID: 8248849
[TBL] [Abstract][Full Text] [Related]
8. Dopamine receptor pharmacology.
Seeman P; Van Tol HH
Curr Opin Neurol Neurosurg; 1993 Aug; 6(4):602-8. PubMed ID: 8104554
[TBL] [Abstract][Full Text] [Related]
9. (Aryloxy)alkylamines as selective human dopamine D4 receptor antagonists: potential antipsychotic agents.
Unangst PC; Capiris T; Connor DT; Doubleday R; Heffner TG; MacKenzie RG; Miller SR; Pugsley TA; Wise LD
J Med Chem; 1997 Dec; 40(25):4026-9. PubMed ID: 9406594
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms of dopamine D2-like (D2, D3, and D4) receptors in schizophrenia.
Ohara K; Nakamura Y; Xie DW; Ishigaki T; Deng ZL; Tani K; Zhang HY; Kondo N; Liu JC; Miyasato K; Ohara K
Biol Psychiatry; 1996 Dec; 40(12):1209-17. PubMed ID: 8959285
[TBL] [Abstract][Full Text] [Related]
11. Dopamine D2 and D4 receptor ligands: relation to antipsychotic action.
Wilson JM; Sanyal S; Van Tol HH
Eur J Pharmacol; 1998 Jun; 351(3):273-86. PubMed ID: 9721018
[TBL] [Abstract][Full Text] [Related]
12. Association study between the dopamine D4 receptor gene and schizophrenia.
Petronis A; Macciardi F; Athanassiades A; Paterson AD; Verga M; Meltzer HY; Cola P; Buchanan JA; Van Tol HH; Kennedy JL
Am J Med Genet; 1995 Oct; 60(5):452-5. PubMed ID: 8546161
[TBL] [Abstract][Full Text] [Related]
13. Dopamine D4 receptors: a new opportunity for research on schizophrenia.
Liégeois J; Eyrolles L; Bruhwyler J; Delarge J
Curr Med Chem; 1998 Apr; 5(2):77-100. PubMed ID: 9481035
[TBL] [Abstract][Full Text] [Related]
14. Effects of dopamine D4 receptor-selective antagonists on motor hyperactivity in rats with neonatal 6-hydroxydopamine lesions.
Zhang K; Davids E; Tarazi FI; Baldessarini RJ
Psychopharmacology (Berl); 2002 Apr; 161(1):100-6. PubMed ID: 11967637
[TBL] [Abstract][Full Text] [Related]
15. New perspectives on biological treatment of schizophrenia.
Lingjaerde O
Acta Psychiatr Scand Suppl; 1994; 384():102-7. PubMed ID: 7879631
[TBL] [Abstract][Full Text] [Related]
16. KKHA-761, a potent D3 receptor antagonist with high 5-HT1A receptor affinity, exhibits antipsychotic properties in animal models of schizophrenia.
Park WK; Jeong D; Cho H; Lee SJ; Cha MY; Pae AN; Choi KI; Koh HY; Kong JY
Pharmacol Biochem Behav; 2005 Oct; 82(2):361-72. PubMed ID: 16216322
[TBL] [Abstract][Full Text] [Related]
17. Dopamine receptors and schizophrenia.
Reynolds GP
Biochem Soc Trans; 1996 Feb; 24(1):202-5. PubMed ID: 8674664
[No Abstract] [Full Text] [Related]
18. Comparative pharmacological and functional analysis of the human dopamine D4.2 and D4.10 receptor variants.
Jovanovic V; Guan HC; Van Tol HH
Pharmacogenetics; 1999 Oct; 9(5):561-8. PubMed ID: 10591536
[TBL] [Abstract][Full Text] [Related]
19. Chromeno[3,4-c]pyridin-5-ones: selective human dopamine D4 receptor antagonists as potential antipsychotic agents.
Unangst PC; Capiris T; Connor DT; Heffner TG; MacKenzie RG; Miller SR; Pugsley TA; Wise LD
J Med Chem; 1997 Aug; 40(17):2688-93. PubMed ID: 9276014
[TBL] [Abstract][Full Text] [Related]
20. Penile erection and yawning induced by dopamine D2-like receptor agonists in rats: influence of strain and contribution of dopamine D2, but not D3 and D4 receptors.
Depoortère R; Bardin L; Rodrigues M; Abrial E; Aliaga M; Newman-Tancredi A
Behav Pharmacol; 2009 Jul; 20(4):303-11. PubMed ID: 19584712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
